{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T21:00:56Z","timestamp":1774990856751,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ackdjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1053\/j.ackd.2019.08.002","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T19:14:01Z","timestamp":1583435641000},"page":"50-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Radiocontrast Toxicity"],"prefix":"10.1053","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4918-4149","authenticated-orcid":false,"given":"Staci","family":"Leisman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1053\/j.ackd.2019.08.002_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/jama.1978.03280290045019","article-title":"Acute renal failure. Association with administration of radiographic contrast material","volume":"239","author":"Krumlovsky","year":"1978","journal-title":"J Am Med Assoc"},{"issue":"5","key":"10.1053\/j.ackd.2019.08.002_bib2","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/ajkd.2002.32766","article-title":"Hospital-acquired renal insufficiency","volume":"39","author":"Nash","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ackd.2019.08.002_bib3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1681\/ASN.2016010021","article-title":"Estimating the risk of radiocontrast-associated nephropathy","volume":"28","author":"Wilhelm-Leen","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ackd.2019.08.002_bib4","first-page":"603","article-title":"Outcomes after angiography with sodium bicarbonate and acetylcysteine","volume":"378","author":"Weisbord","year":"2018"},{"issue":"8","key":"10.1053\/j.ackd.2019.08.002_bib5","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.mayocp.2015.05.016","article-title":"Risk of acute kidney injury, dialysis, and mortality in patients with chronic kidney disease after intravenous contrast material exposure","volume":"90","author":"McDonald","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.ackd.2019.08.002_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jcrc.2019.02.003","article-title":"Acute kidney injury following contrast media administration in the septic patient: a retrospective propensity-matched analysis","volume":"51","author":"Hinson","year":"2019","journal-title":"J Crit Care"},{"issue":"2","key":"10.1053\/j.ackd.2019.08.002_bib7","first-page":"222","article-title":"Contemporary use of and outcomes associated with ultra-low contrast volume in patients undergoing percutaneous coronary interventions","volume":"93","author":"Gurm","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"10.1053\/j.ackd.2019.08.002_bib8","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2214\/AJR.07.3280","article-title":"Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity","volume":"191","author":"Newhouse","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1053\/j.ackd.2019.08.002_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000494047","article-title":"Intra-arterial versus Intravenous contrast and renal injury in Chronic kidney disease: a propensity-matched analysis","volume":"141","author":"Chaudhury","year":"2019","journal-title":"Nephron"},{"issue":"5","key":"10.1053\/j.ackd.2019.08.002_bib10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jcin.2017.10.018","article-title":"Trends in contrast volume Use and incidence of acute kidney injury in patients undergoing percutaneous coronary intervention: insights from blue Cross Blue Shield of Michigan Cardiovascular Collaborative (BMC2)","volume":"11","author":"Gurm","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.ackd.2019.08.002_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3763250","article-title":"Histopathological evaluation of contrast-induced acute kidney injury rodent models","volume":"2016","author":"Kiss","year":"2016","journal-title":"Biomed Res Int"},{"issue":"3","key":"10.1053\/j.ackd.2019.08.002_bib12","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1148\/radiol.12120044","article-title":"Iodinated contrast media differentially affect afferent and efferent arteriolar tone and reactivity in mice: a possible explanation for reduced glomerular filtration rate","volume":"265","author":"Liu","year":"2012","journal-title":"Radiology"},{"issue":"8","key":"10.1053\/j.ackd.2019.08.002_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/RLI.0b013e3181d77eed","article-title":"Constriction of the vasa recta, the vessels supplying the area at risk for acute kidney injury, by four different iodinated contrast media, evaluating ionic, nonionic, monomeric and dimeric agents","volume":"45","author":"Sendeski","year":"2010","journal-title":"Invest Radiol"},{"issue":"12","key":"10.1053\/j.ackd.2019.08.002_bib14","doi-asserted-by":"crossref","first-page":"F1592","DOI":"10.1152\/ajprenal.00471.2012","article-title":"Iodinated contrast media cause endothelial damage leading to vasoconstriction of human and rat vasa recta","volume":"303","author":"Sendeski","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"issue":"8","key":"10.1053\/j.ackd.2019.08.002_bib15","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3109\/0886022X.2015.1068031","article-title":"Role of ERK1\/2 and JNK phosphorylation in iodine contrast agent-induced apoptosis in diabetic rat kidneys","volume":"37","author":"Jiao","year":"2015","journal-title":"Ren Fail"},{"issue":"11","key":"10.1053\/j.ackd.2019.08.002_bib16","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1681\/ASN.2006111216","article-title":"Viscosity of contrast media perturbs renal hemodynamics","volume":"18","author":"Seeliger","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2019.08.002_bib17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0002-9343(97)00150-2","article-title":"Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality","volume":"103","author":"McCullough","year":"1997","journal-title":"Am J Med"},{"issue":"1","key":"10.1053\/j.ackd.2019.08.002_bib18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/ki.1995.32","article-title":"Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study","volume":"47","author":"Rudnick","year":"1995","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ackd.2019.08.002_bib19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa021833","article-title":"Nephrotoxic effects in high-risk patients undergoing angiography","volume":"348","author":"Aspelin","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.ackd.2019.08.002_bib20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.7326\/M15-1402","article-title":"Comparative effect of contrast media type on the incidence of contrast-induced nephropathy: a systematic review and meta-analysis","volume":"164","author":"Eng","year":"2016","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1053\/j.ackd.2019.08.002_bib21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1538-7836.2009.03698.x","article-title":"Incidence and predictors of contrast-induced nephropathy following CT-angiography for clinically suspected acute pulmonary embolism","volume":"8","author":"Kooiman","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1053\/j.ackd.2019.08.002_bib22","first-page":"1393","article-title":"A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation","volume":"44","author":"Mehran","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.ackd.2019.08.002_bib23","article-title":"The investigation of TIMI risk index for prediction of contrast-induced acute kidney injury in patients with ST elevation myocardial infarction","author":"\u00c7\u0131nar","year":"2019","journal-title":"Acta Cardiol"},{"issue":"2","key":"10.1053\/j.ackd.2019.08.002_bib24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1161\/CIRCINTERVENTIONS.113.000778","article-title":"Risk of acute kidney injury after percutaneous coronary interventions using radial versus femoral vascular access insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium","volume":"7","author":"Kooiman","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1053\/j.ackd.2019.08.002_bib25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijcard.2018.08.026","article-title":"Impact of vascular access on the development of contrast induced nephropathy in patients undergoing coronary angiography and\/or percutaneous coronary intervention","volume":"275","author":"Barbieri","year":"2019","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1053\/j.ackd.2019.08.002_bib26","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamacardio.2017.2156","article-title":"Association of variation in contrast volume with acute kidney injury in patients undergoing percutaneous coronary intervention","volume":"2","author":"Amin","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"6 Pt 1","key":"10.1053\/j.ackd.2019.08.002_bib27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0002-9343(89)90437-3","article-title":"Dosing of contrast material to prevent contrast nephropathy in patients with renal disease","volume":"86","author":"Cigarroa","year":"1989","journal-title":"Am J Med"},{"issue":"3","key":"10.1053\/j.ackd.2019.08.002_bib28","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7326\/0003-4819-150-3-200902030-00006","article-title":"Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality","volume":"150","author":"Marenzi","year":"2009","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1053\/j.ackd.2019.08.002_bib29","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jacc.2011.05.023","article-title":"Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions","volume":"58","author":"Gurm","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1053\/j.ackd.2019.08.002_bib30","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1001\/jama.291.19.2328","article-title":"Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial","volume":"291","author":"Merten","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1053\/j.ackd.2019.08.002_bib31","series-title":"Contrast-Induced Nephropathy: Comparative Effectiveness of Preventive Measures","article-title":"AHRQ Comparative Effectiveness Reviews","author":"Subramaniam","year":"2016"},{"issue":"9","key":"10.1053\/j.ackd.2019.08.002_bib32","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1253\/circj.CJ-12-0096","article-title":"Sodium bicarbonate therapy for the prevention of contrast-induced acute kidney injury - a systematic review and meta-analysis","volume":"76","author":"Jang","year":"2012","journal-title":"Circ J"},{"issue":"30","key":"10.1053\/j.ackd.2019.08.002_bib33","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1093\/eurheartj\/eht009","article-title":"Prevention of contrast-induced nephropathy with Na\/K citrate","volume":"34","author":"Markota","year":"2013","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1053\/j.ackd.2019.08.002_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003171","article-title":"Excessively high hydration volume may not be associated with decreased risk of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with renal insufficiency","volume":"5","author":"Liu","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"9931","key":"10.1053\/j.ackd.2019.08.002_bib35","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0140-6736(14)60689-9","article-title":"Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial","volume":"383","author":"Brar","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1053\/j.ackd.2019.08.002_bib36","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0735-1097(98)00574-9","article-title":"A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation","volume":"33","author":"Stevens","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1053\/j.ackd.2019.08.002_bib37","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCULATIONAHA.111.030759","article-title":"Renal insufficiency after contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury","volume":"124","author":"Briguori","year":"2011","journal-title":"Circulation"},{"issue":"11","key":"10.1053\/j.ackd.2019.08.002_bib38","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/CIRCULATIONAHA.111.038943","article-title":"ACT Investigators. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced Nephropathy Trial (ACT)","volume":"124","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.ackd.2019.08.002_bib39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jacc.2013.04.105","volume":"63","author":"Leoncini","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1053\/j.ackd.2019.08.002_bib40","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/0003319718801246","article-title":"Comparative Efficacy of statins for prevention of contrast-induced acute kidney injury in patients with chronic kidney disease: a Network meta-analysis","volume":"70","author":"Zhou","year":"2019","journal-title":"Angiology"},{"issue":"11","key":"10.1053\/j.ackd.2019.08.002_bib41","first-page":"1287","article-title":"Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation with IVUS Guidance in coRonary angioplasTy) randomized controlled trial","volume":"7","author":"Mariani","year":"2014"},{"issue":"2","key":"10.1053\/j.ackd.2019.08.002_bib42","first-page":"25","article-title":"Centers for Disease Control and Prevention. Fibrosing skin condition among patients with renal disease--United States and Europe, 1997-2002","volume":"51","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1053\/j.ackd.2019.08.002_bib43","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/ndt\/gfk062","article-title":"Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?","volume":"21","author":"Grobner","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1053\/j.ackd.2019.08.002_bib44","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jaad.2010.08.041","article-title":"Nephrogenic systemic fibrosis: Clinicopathological definition and workup recommendations","volume":"65","author":"Girardi","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1053\/j.ackd.2019.08.002_bib45","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.00166.2016","article-title":"Pathophysiology of gadolinium-associated systemic fibrosis","volume":"311","author":"Wagner","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"10.1053\/j.ackd.2019.08.002_bib46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/RLI.0000000000000000","article-title":"Incidence of nephrogenic systemic fibrosis in patients undergoing dialysis after contrast-enhanced magnetic resonance imaging with gadolinium-based contrast agents: the Prospective Fibrose Nephrogenique Systemique study","volume":"49","author":"Amet","year":"2014","journal-title":"Invest Radiol"},{"issue":"6","key":"10.1053\/j.ackd.2019.08.002_bib47","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/RLI.0000000000000145","article-title":"Nephrogenic systemic fibrosis risk after liver magnetic resonance imaging with gadoxetate disodium in patients with moderate to severe renal impairment: results of a prospective, open-label, multicenter study","volume":"50","author":"Lauenstein","year":"2015","journal-title":"Invest Radiol"},{"issue":"5","key":"10.1053\/j.ackd.2019.08.002_bib48","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD","volume":"63","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2019.08.002_bib49","series-title":"FDA Drug Safety Communication: New warnings for using gadolinium-based contrast agents in patients with kidney dysfunction","author":"Food","year":"2010"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559519301429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559519301429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:02:50Z","timestamp":1761548570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559519301429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1548559519301429"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2019.08.002","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiocontrast Toxicity","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2019.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}